Dr. Davies also leads a translational laboratory research program. His research has identified clinical associations of oncogenic mutations and signaling pathways; novel strategies to overcome resistance to targeted and immune therapies; and new predictors and therapeutic approaches for central nervous system (CNS) metastases from melanoma. Dr. Davies is an elected member of the American Society for Clinical Investigation, and he is the co-leader of the MD Anderson Melanoma Moon Shot Program.